Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancer von O'Malley, David M., Oaknin, Ana, Monk, Bradley J., Selle, Frédéric, Rojas, Carlos, Gladieff, Laurence, Berton, Dominique, Leary, Alexandra, Moore, Kathleen N., Estevez-Diz, Maria D.P., Hardy-Bessard, Anne-Claire, Alexandre, Jérôme, Opperman, Christina P., de Azevedo, Carla Rameri A.S., Randall, Leslie M., Feliu, Waldo Ortuzar, Ancukiewicz, Marek, Ray-Coquard, Isabelle

Volltext